PHILADELPHIA — Pharmaceutical company Incyte will pay $12.6 million in a settlement to resolve allegations it violated the False Claims Act, the Justice Department announced Tuesday, adding that there has been no determination of liability. The company was accused of using an independent foundation to pay copays of certain people taking its drug Jakafi, which has been approved to treat a type of bone marrow cancer.

%d bloggers like this: